206
Views
12
CrossRef citations to date
0
Altmetric
Review

Immunopathogenesis of allergic disorders: current concepts

&
Pages 211-226 | Published online: 10 Jan 2014

References

  • von Pirquet C. Allergy. In: Clinical Aspects of Immunology. Gell PGH, Coombs RRA (Eds). Blackwell Scientific, Oxford, UK (1963).
  • Kay AB. Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344(1), 30–37 (2001).
  • Akdis CA. Allergy and hypersensitivity: mechanisms of allergic disease. Curr. Opin. Immunol. 18(6), 718–726 (2006).
  • Murphy K, Travers P, Walport M. Allergy and hypersensitivity. In: Janeway’s Immunobiology (17th Edition). Garland Science, Taylor & Francis Group, Abingdon, UK (2008).
  • The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351(9111), 1225–1232 (1998).
  • Busse WW. The role of allergy in disease. Immunol. Rev. 242(1), 5–9 (2011).
  • Asher MI, Montefort S, Björkstén B et al.; ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368(9537), 733–743 (2006).
  • Paramesh H. Epidemiology of asthma in India. Indian J. Pediatr. 69(4), 309–312 (2002).
  • Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 296(5567), 490–494 (2002).
  • Frei R, Lauener RP, Crameri R, O’Mahony L. Microbiota and dietary interactions: an update to the hygiene hypothesis? Allergy 67(4), 451–461 (2012).
  • Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107(1), 129–134 (2001).
  • Wickens K, Pearce N, Crane J, Beasley R. Antibiotic use in early childhood and the development of asthma. Clin. Exp. Allergy 29(6), 766–771 (1999).
  • van den Biggelaar AH, van Ree R, Rodrigues LC et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 356(9243), 1723–1727 (2000).
  • Dickey BF. Exoskeletons and exhalation. N. Engl. J. Med. 357(20), 2082–2084 (2007).
  • Wallmann J, Pali-Schöll I, Jensen-Jarolim E. Anti-Ids in allergy: timeliness of a classic concept. World Allergy Organ. J. 3(6), 195–201 (2010).
  • Gould HJ, Sutton BJ, Beavil AJ et al. The biology of IGE and the basis of allergic disease. Annu. Rev. Immunol. 21, 579–628 (2003).
  • Martino DJ, Prescott SL. Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease. Allergy 65(1), 7–15 (2010).
  • Prescott S, Saffery R. The role of epigenetic dysregulation in the epidemic of allergic disease. Clin. Epigenetics 2(2), 223–232 (2011).
  • Brand S, Kesper DA, Teich R et al. DNA methylation of TH1/TH2 cytokine genes affects sensitization and progress of experimental asthma. J. Allergy Clin. Immunol. 129(6), 1602.e6–1610.e6 (2012).
  • Wilson CB, Rowell E, Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 9(2), 91–105 (2009).
  • Conrad ML, Ferstl R, Teich R et al. Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78. J. Exp. Med. 206(13), 2869–2877 (2009).
  • Kitaura J, Song J, Tsai M et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc. Natl Acad. Sci. USA 100(22), 12911–12916 (2003).
  • Bax HJ, Keeble AH, Gould HJ. Cytokinergic IgE action in mast cell activation. Front. Immunol. 3, 229 (2012).
  • Kawakami T, Kitaura J. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J. Immunol. 175(7), 4167–4173 (2005).
  • Hackett TL, Singhera GK, Shaheen F et al. Intrinsic phenotypic differences of asthmatic epithelium and its inflammatory responses to respiratory syncytial virus and air pollution. Am. J. Respir. Cell Mol. Biol. 45(5), 1090–1100 (2011).
  • Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat. Rev. Immunol. 8(3), 205–217 (2008).
  • Reber L, Da Silva CA, Frossard N. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur. J. Pharmacol. 533(1–3), 327–340 (2006).
  • Veres TZ, Voedisch S, Spies E, Tschernig T, Braun A. Spatiotemporal and functional behavior of airway dendritic cells visualized by two-photon microscopy. Am. J. Pathol. 179(2), 603–609 (2011).
  • Blank F, Wehrli M, Lehmann A et al. Macrophages and dendritic cells express tight junction proteins and exchange particles in an in vitro model of the human airway wall. Immunobiology 216(1–2), 86–95 (2011).
  • Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat. Rev. Immunol. 8(3), 193–204 (2008).
  • Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8(3), 183–192 (2008).
  • Lambrecht BN, Hammad H. The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 376(9743), 835–843 (2010).
  • Meyer EH, Goya S, Akbari O et al. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl Acad. Sci. USA 103(8), 2782–2787 (2006).
  • Kassianos AJ, Jongbloed SL, Hart DN, Radford KJ. Isolation of human blood DC subtypes. Methods Mol. Biol. 595, 45–54 (2010).
  • Louten J, Boniface K, de Waal Malefyt R. Development and function of TH17 cells in health and disease. J. Allergy Clin. Immunol. 123(5), 1004–1011 (2009).
  • Akbari O, Faul JL, Hoyte EG et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354(11), 1117–1129 (2006).
  • Erpenbeck VJ, Hohlfeld JM, Volkmann B et al. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J. Allergy Clin. Immunol. 111(6), 1319–1327 (2003).
  • Bryce PJ. Revolution 9: the backwards and forwards evidence surrounding interleukin-9. Am. J. Respir. Crit. Care Med. 183(7), 834–835 (2011).
  • Nembrini C, Marsland BJ, Kopf M. IL-17-producing T cells in lung immunity and inflammation. J. Allergy Clin. Immunol. 123(5), 986–94; quiz 995 (2009).
  • Neill DR, Wong SH, Bellosi A et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464(7293), 1367–1370 (2010).
  • Veldhoen M, Uyttenhove C, van Snick J et al. Transforming growth factor-β ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9(12), 1341–1346 (2008).
  • Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J. Allergy Clin. Immunol. 127(1), 18–27; quiz 28 (2011).
  • Schaub B, Liu J, Höppler S et al. Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. J. Allergy Clin. Immunol. 123(4), 774.e5–782.e5 (2009).
  • Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10(2), 103–110 (2010).
  • Drolet JP, Frangie H, Guay J, Hajoui O, Hamid Q, Mazer BD. B lymphocytes in inflammatory airway diseases. Clin. Exp. Allergy 40(6), 841–849 (2010).
  • Prussin C, Metcalfe DD. 5. IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol. 117(2 Suppl. Mini-Primer), S450–S456 (2006).
  • Humbles AA, Lloyd CM, McMillan SJ et al. A critical role for eosinophils in allergic airways remodeling. Science 305(5691), 1776–1779 (2004).
  • Marone G, Triggiani M, de Paulis A. Mast cells and basophils: friends as well as foes in bronchial asthma? Trends Immunol. 26(1), 25–31 (2005).
  • Alcorn JF, Crowe CR, Kolls JK. TH17 cells in asthma and COPD. Annu. Rev. Physiol. 72, 495–516 (2010).
  • Sampson AP. The role of eosinophils and neutrophils in inflammation. Clin. Exp. Allergy 30(Suppl. 1), 22–27 (2000).
  • Ziegler SF, Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat. Immunol. 11(4), 289–293 (2010).
  • Kurowska-Stolarska M, Hueber A, Stolarski B, McInnes IB. Interleukin-33: a novel mediator with a role in distinct disease pathologies. J. Intern. Med. 269(1), 29–35 (2011).
  • Alam R. Chemokines in allergic inflammation. J. Allergy Clin. Immunol. 99(3), 273–277 (1997).
  • Hassan M, Jo T, Risse PA et al. Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma. J. Allergy Clin. Immunol. 125(5), 1037.e3–1045.e3 (2010).
  • Paredi P, Barnes PJ. The airway vasculature: recent advances and clinical implications. Thorax 64(5), 444–450 (2009).
  • Fahy JV, Dickey BF. Airway mucus function and dysfunction. N. Engl. J. Med. 363(23), 2233–2247 (2010).
  • Chen G, Korfhagen TR, Xu Y et al. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J. Clin. Invest. 119(10), 2914–2924 (2009).
  • Barnes PJ. Pathophysiology of allergic inflammation. Immunol. Rev. 242(1), 31–50 (2011).
  • Holgate ST. The epidemic of allergy and asthma. Nature 402(Suppl. 6760), B2–B4 (1999).
  • Agache I, Akdis C, Jutel M, Virchow JC. Untangling asthma phenotypes and endotypes. Allergy 67(7), 835–846 (2012).
  • Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat. Med. 18(5), 716–725 (2012).
  • Hallstrand TS, Moody MW, Aitken ML, Henderson WR Jr. Airway immunopathology of asthma with exercise-induced bronchoconstriction. J. Allergy Clin. Immunol. 116(3), 586–593 (2005).
  • Moore WC, Meyers DA, Wenzel SE et al.; National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 181(4), 315–323 (2010).
  • Miranda C, Busacker A, Balzar S, Trudeau J, Wenzel SE. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J. Allergy Clin. Immunol. 113(1), 101–108 (2004).
  • Lajoie S, Lewkowich IP, Suzuki Y et al. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 11(10), 928–935 (2010).
  • Eiwegger T, Akdis CA. IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma. Eur. J. Immunol. 41(6), 1535–1538 (2011).
  • Doe C, Bafadhel M, Siddiqui S et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 138(5), 1140–1147 (2010).
  • Laidlaw TM, Kidder MS, Bhattacharyya N et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood 119(16), 3790–3798 (2012).
  • Karjalainen EM, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am. J. Respir. Crit. Care Med. 161(6), 2086–2091 (2000).
  • Bisgaard H, Bønnelykke K. Long-term studies of the natural history of asthma in childhood. J. Allergy Clin. Immunol. 126(2), 187–97; quiz 198 (2010).
  • Kim HY, DeKruyff RH, Umetsu DT. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat. Immunol. 11(7), 577–584 (2010).
  • Hammad H, Plantinga M, Deswarte K et al. Inflammatory dendritic cells – not basophils – are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J. Exp. Med. 207(10), 2097–2111 (2010).
  • Dixon AE, Pratley RE, Forgione PM et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J. Allergy Clin. Immunol. 128(3), 508.e1–515.e1 (2011).
  • Burns P, Powe DG, Jones NS. Idiopathic rhinitis. Curr. Opin. Otolaryngol. Head Neck Surg. 20(1), 1–8 (2012).
  • Bousquet J, Schünemann HJ, Samolinski B et al.; World Health Organization Collaborating Center for Asthma and Rhinitis. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J. Allergy Clin. Immunol. 130(5), 1049–1062 (2012).
  • Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 108(Suppl. 5), S147–S334 (2001).
  • Powe DG, Jagger C, Kleinjan A, Carney AS, Jenkins D, Jones NS. ‘Entopy’: localized mucosal allergic disease in the absence of systemic responses for atopy. Clin. Exp. Allergy 33(10), 1374–1379 (2003).
  • Powe DG, Jones NS. Local mucosal immunoglobulin E production: does allergy exist in non-allergic rhinitis? Clin. Exp. Allergy 36(11), 1367–1372 (2006).
  • Holgate ST. Innate and adaptive immune responses in asthma. Nat. Med. 18(5), 673–683 (2012).
  • Bieber T. Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine. Allergy 67(12), 1475–1482 (2012).
  • Butler M, Atherton D, Levinsky RJ. Quantitative and functional deficit of suppressor T cells in children with atopic eczema. Clin. Exp. Immunol. 50(1), 92–98 (1982).
  • Sloper KS, Wadsworth J, Brostoff J. Children with atopic eczema. II: immunological findings associated with dietary manipulations. Q. J. Med. 80(292), 695–705 (1991).
  • Werfel T, Breuer K. Role of food allergy in atopic dermatitis. Curr. Opin. Allergy Clin. Immunol. 4(5), 379–385 (2004).
  • Hadis U, Wahl B, Schulz O et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 34(2), 237–246 (2011).
  • Corazza N, Kaufmann T. Novel insights into mechanisms of food allergy and allergic airway inflammation using experimental mouse models. Allergy 67(12), 1483–1490 (2012).
  • Smit JJ, Bol-Schoenmakers M, Hassing I et al. The role of intestinal dendritic cells subsets in the establishment of food allergy. Clin. Exp. Allergy 41(6), 890–898 (2011).
  • Järvinen KM, Sicherer SH. Diagnostic oral food challenges: procedures and biomarkers. J. Immunol. Methods 383(1–2), 30–38 (2012).
  • Geuking MB, Cahenzli J, Lawson MA et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 34(5), 794–806 (2011).
  • Cardoso CR, Teixeira G, Provinciatto PR et al. Modulation of mucosal immunity in a murine model of food-induced intestinal inflammation. Clin. Exp. Allergy 38(2), 338–349 (2008).
  • Pichler WJ. Drug hypersensitivity reactions: classification and relationship to T cell activation. In: Drug Hypersensitivity. Karger, Basel, Switzerland, 168–189 (2007).
  • Doña I, Blanca-López N, Torres MJ et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J. Investig. Allergol. Clin. Immunol. 22(5), 363–371 (2012).
  • Sampson HA, Muñoz-Furlong A, Bock SA et al. Symposium on the definition and management of anaphylaxis: summary report. J. Allergy Clin. Immunol. 115(3), 584–591 (2005).
  • Simons FE. Anaphylaxis pathogenesis and treatment. Allergy 66(Suppl. 95), 31–34 (2011).
  • Simons FE. Anaphylaxis. J. Allergy Clin. Immunol. 125(2 Suppl. 2), S161–S181 (2010).
  • Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr. Opin. Allergy Clin. Immunol. 10(4), 354–361 (2010).
  • Finkelman FD. Anaphylaxis: lessons from mouse models. J. Allergy Clin. Immunol. 120(3), 506–15; quiz 516 (2007).
  • Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat. Rev. Immunol. 10(4), 225–235 (2010).
  • Saenz SA, Siracusa MC, Perrigoue JG et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 464(7293), 1362–1366 (2010).
  • Wang YH, Angkasekwinai P, Lu N et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J. Exp. Med. 204(8), 1837–1847 (2007).
  • Lu TX, Hartner J, Lim EJ et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-γ pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J. Immunol. 187(6), 3362–3373 (2011).
  • Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 3(5), 405–412 (2003).
  • Marshall JS. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4(10), 787–799 (2004).
  • Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6(3), 218–230 (2006).
  • Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22, 789–815 (2004).
  • Holgate ST. Epithelium dysfunction in asthma. J. Allergy Clin. Immunol. 120(6), 1233–1244; quiz 1245 (2007).
  • Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun. 7(2), 95–100 (2006).
  • Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism* in the 5’ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell Mol. Biol. 20(5), 976–983 (1999).
  • Eder W, Klimecki W, Yu L et al.; ALEX Study Team. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J. Allergy Clin. Immunol. 113(3), 482–488 (2004).
  • Hysi P, Kabesch M, Moffatt MF et al. NOD1 variation, immunoglobulin E and asthma. Hum. Mol. Genet. 14(7), 935–941 (2005).
  • Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat. Rev. Immunol. 8(3), 169–182 (2008).
  • Vercelli D. Learning from discrepancies: CD14 polymorphisms, atopy and the endotoxin switch. Clin. Exp. Allergy 33(2), 153–155 (2003).
  • Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L. Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma. Am. J. Respir. Crit. Care Med. 158(6), 1958–1962 (1998).
  • Silverman ES, Palmer LJ, Subramaniam V et al. Transforming growth factor-β 1 promoter polymorphism C-509T is associated with asthma. Am. J. Respir. Crit. Care Med. 169(2), 214–219 (2004).
  • Litonjua AA, Tantisira KG, Lake S et al. Polymorphisms in signal transducer and activator of transcription 3 and lung function in asthma. Respir. Res. 6, 52 (2005).
  • Finkelman FD, Vercelli D. Advances in asthma, allergy mechanisms, and genetics in 2006. J. Allergy Clin. Immunol. 120(3), 544–550 (2007).
  • Wu H, Romieu I, Shi M et al. Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans. J. Allergy Clin. Immunol. 125(2), 321–327.e13 (2010).
  • Mathias RA, Grant AV, Rafaels N et al. A genome-wide association study on African-ancestry populations for asthma. J. Allergy Clin. Immunol. 125(2), 336–346.e4 (2010).
  • Schedel M, Carr D, Klopp N et al. A signal transducer and activator of transcription 6 haplotype influences the regulation of serum IgE levels. J. Allergy Clin. Immunol. 114(5), 1100–1105 (2004).
  • Kabesch M, Tzotcheva I, Carr D et al. A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J. Allergy Clin. Immunol. 112(5), 893–898 (2003).
  • Loza MJ, Chang BL. Association between Q551R IL4R genetic variants and atopic asthma risk demonstrated by meta-analysis. J. Allergy Clin. Immunol. 120(3), 578–585 (2007).
  • Palmer CN, Ismail T, Lee SP et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. J. Allergy Clin. Immunol. 120(1), 64–68 (2007).
  • Söderhäll C, Marenholz I, Kerscher T et al. Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis. PLoS Biol. 5(9), e242 (2007).
  • Chavanas S, Bodemer C, Rochat A et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat. Genet. 25(2), 141–142 (2000).
  • Van Eerdewegh P, Little RD, Dupuis J et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418(6896), 426–430 (2002).
  • Balaci L, Spada MC, Olla N et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am. J. Hum. Genet. 80(6), 1103–1114 (2007).
  • Vercelli D. Genetics and biology of asthma 2010: La’ ci darem la mano. J. Allergy Clin. Immunol. 125(2), 347–348 (2010).
  • Bloemen K, Verstraelen S, Van Den Heuvel R, Witters H, Nelissen I, Schoeters G. The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol. Lett. 113(1), 6–18 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.